Molecular Monitoring in Endometrial Cancer-Ready for Prime Time?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 36354753.
- Also identified by DOI 10.1158/1078-0432.CCR-22-2781.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Efforts are under way to define the role of minimally invasive strategies for molecular monitoring and risk stratification in endometrial cancer. A recent publication aims to define the association between circulating tumor DNA level and disease stage in patients with newly diagnosed endometrial cancer and determine whether sequencing of longitudinal cell-free DNA samples can be used for disease monitoring and detection of progression or recurrence. These results accelerate the current knowledge of molecular follow-up in endometrial cancer. See related article by Ashley et al., p. 410.
Medical subject headings
- Endometrial Neoplasms
- Circulating Tumor DNA